Traded Dec 9, 2025 · filed 3 days laterNot under a reported trading plan
Jazz Pharmaceuticals's SVP, Technical Operations sold $379K of Jazz Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Traded Nov 19, 2025 · Filed Nov 22, 2025
Not classified as an open-market trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
other
Code D — not an open-market trade
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
Traded Dec 9, 2025 · filed 3 days laterNot under a reported trading plan
Jazz Pharmaceuticals's SVP, Technical Operations sold $379K of Jazz Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Traded Dec 5, 2025 · filed 5 days later
Routine share withholding; mechanical by default.
Patricia Carr (SVP, Chief Accounting Officer) sold ~$27K of Jazz Pharmaceuticals
Automatic sale